Annual EBIT
-$24.08 M
+$5.62 M+18.92%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual earnings before interest & taxes is -$24.08 million, with the most recent change of +$5.62 million (+18.92%) on December 31, 2023.
- During the last 3 years, CAPR annual EBIT has fallen by -$10.39 million (-75.88%).
- CAPR annual EBIT is now -950.75% below its all-time high of $2.83 million, reached on December 31, 2017.
Performance
CAPR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$13.01 M
-$1.42 M-12.24%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly earnings before interest & taxes is -$13.01 million, with the most recent change of -$1.42 million (-12.24%) on September 30, 2024.
- Over the past year, CAPR quarterly EBIT has dropped by -$1.42 million (-12.24%).
- CAPR quarterly EBIT is now -205.04% below its all-time high of $12.39 million, reached on December 31, 2017.
Performance
CAPR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$36.15 M
-$6.15 M-20.48%
September 30, 2024
Summary
- As of February 7, 2025, CAPR TTM earnings before interest & taxes is -$36.15 million, with the most recent change of -$6.15 million (-20.48%) on September 30, 2024.
- Over the past year, CAPR TTM EBIT has dropped by -$6.15 million (-20.48%).
- CAPR TTM EBIT is now -1377.19% below its all-time high of $2.83 million, reached on December 31, 2017.
Performance
CAPR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CAPR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.9% | -12.2% | -20.5% |
| 3 y3 years | -75.9% | -61.3% | -21.7% |
| 5 y5 years | -57.1% | -61.3% | -21.7% |
CAPR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.0% | +18.9% | -915.4% | at low | -72.6% | at low |
| 5 y | 5-year | -211.3% | +18.9% | -915.4% | at low | -396.3% | at low |
| alltime | all time | -950.8% | +18.9% | -205.0% | at low | -1377.2% | at low |
Capricor Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.01 M(+12.2%) | -$36.15 M(+20.5%) |
| Jun 2024 | - | -$11.59 M(+12.9%) | -$30.00 M(+14.7%) |
| Mar 2024 | - | -$10.27 M(+701.2%) | -$26.16 M(+8.6%) |
| Dec 2023 | -$24.08 M(-18.9%) | -$1.28 M(-81.3%) | -$24.08 M(-22.0%) |
| Sep 2023 | - | -$6.86 M(-11.4%) | -$30.86 M(+1.3%) |
| Jun 2023 | - | -$7.75 M(-5.3%) | -$30.48 M(+1.4%) |
| Mar 2023 | - | -$8.18 M(+1.5%) | -$30.05 M(+1.2%) |
| Dec 2022 | -$29.70 M(+41.8%) | -$8.07 M(+24.5%) | -$29.70 M(+6.0%) |
| Sep 2022 | - | -$6.48 M(-11.5%) | -$28.01 M(+8.4%) |
| Jun 2022 | - | -$7.32 M(-6.5%) | -$25.85 M(+9.5%) |
| Mar 2022 | - | -$7.83 M(+22.8%) | -$23.61 M(+12.8%) |
| Dec 2021 | -$20.94 M(+52.9%) | -$6.38 M(+47.9%) | -$20.94 M(+11.7%) |
| Sep 2021 | - | -$4.31 M(-15.1%) | -$18.74 M(+2.2%) |
| Jun 2021 | - | -$5.08 M(-1.5%) | -$18.34 M(+9.5%) |
| Mar 2021 | - | -$5.16 M(+23.5%) | -$16.74 M(+22.3%) |
| Dec 2020 | -$13.69 M(+77.0%) | -$4.18 M(+6.8%) | -$13.69 M(+24.5%) |
| Sep 2020 | - | -$3.91 M(+12.2%) | -$10.99 M(+26.3%) |
| Jun 2020 | - | -$3.49 M(+65.5%) | -$8.71 M(+19.5%) |
| Mar 2020 | - | -$2.11 M(+42.1%) | -$7.28 M(-5.8%) |
| Dec 2019 | -$7.73 M(-49.5%) | -$1.48 M(-8.9%) | -$7.73 M(-19.1%) |
| Sep 2019 | - | -$1.63 M(-21.2%) | -$9.56 M(-21.0%) |
| Jun 2019 | - | -$2.07 M(-19.2%) | -$12.10 M(-14.8%) |
| Mar 2019 | - | -$2.56 M(-22.6%) | -$14.20 M(-7.4%) |
| Dec 2018 | -$15.33 M(-641.6%) | -$3.31 M(-20.8%) | -$15.33 M(-4306.1%) |
| Sep 2018 | - | -$4.17 M(+0.2%) | $364.40 K(-80.9%) |
| Jun 2018 | - | -$4.16 M(+12.9%) | $1.91 M(-29.4%) |
| Mar 2018 | - | -$3.69 M(-129.8%) | $2.71 M(-4.4%) |
| Dec 2017 | $2.83 M(-115.3%) | $12.39 M(-571.4%) | $2.83 M(-120.3%) |
| Sep 2017 | - | -$2.63 M(-22.0%) | -$13.97 M(-15.7%) |
| Jun 2017 | - | -$3.37 M(-5.5%) | -$16.58 M(-7.0%) |
| Mar 2017 | - | -$3.56 M(-19.3%) | -$17.82 M(-3.5%) |
| Dec 2016 | -$18.46 M(+46.4%) | -$4.42 M(-15.7%) | -$18.46 M(+6.5%) |
| Sep 2016 | - | -$5.23 M(+13.5%) | -$17.33 M(+16.0%) |
| Jun 2016 | - | -$4.61 M(+9.8%) | -$14.95 M(+11.6%) |
| Mar 2016 | - | -$4.20 M(+28.0%) | -$13.39 M(+6.2%) |
| Dec 2015 | -$12.61 M(+109.6%) | -$3.28 M(+15.2%) | -$12.61 M(+12.6%) |
| Sep 2015 | - | -$2.85 M(-6.9%) | -$11.19 M(+13.9%) |
| Jun 2015 | - | -$3.06 M(-10.3%) | -$9.83 M(+19.2%) |
| Mar 2015 | - | -$3.41 M(+82.8%) | -$8.25 M(+37.1%) |
| Dec 2014 | -$6.02 M(-31.9%) | -$1.87 M(+25.9%) | -$6.02 M(-28.6%) |
| Sep 2014 | - | -$1.48 M(+0.3%) | -$8.43 M(-0.4%) |
| Jun 2014 | - | -$1.48 M(+24.8%) | -$8.47 M(-1.6%) |
| Mar 2014 | - | -$1.19 M(-72.3%) | -$8.61 M(-2.6%) |
| Dec 2013 | -$8.83 M(+326.5%) | -$4.28 M(+181.2%) | -$8.83 M(+79.0%) |
| Sep 2013 | - | -$1.52 M(-6.0%) | -$4.93 M(+24.0%) |
| Jun 2013 | - | -$1.62 M(+14.5%) | -$3.98 M(+105.2%) |
| Mar 2013 | - | -$1.41 M(+271.8%) | -$1.94 M(+49.5%) |
| Dec 2012 | -$2.07 M | -$380.20 K(-32.9%) | -$1.30 M(-49.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$566.20 K(-234.3%) | -$2.58 M(-18.3%) |
| Jun 2012 | - | $421.50 K(-154.6%) | -$3.16 M(-29.2%) |
| Mar 2012 | - | -$771.90 K(-53.6%) | -$4.46 M(-8.7%) |
| Dec 2011 | -$4.88 M(-22.4%) | -$1.66 M(+45.5%) | -$4.89 M(+14.6%) |
| Sep 2011 | - | -$1.14 M(+30.0%) | -$4.26 M(-13.6%) |
| Jun 2011 | - | -$880.20 K(-26.5%) | -$4.93 M(-11.2%) |
| Mar 2011 | - | -$1.20 M(+14.8%) | -$5.55 M(-11.7%) |
| Dec 2010 | -$6.29 M(-20.2%) | -$1.04 M(-42.5%) | -$6.29 M(-7.8%) |
| Sep 2010 | - | -$1.81 M(+20.8%) | -$6.83 M(-2.9%) |
| Jun 2010 | - | -$1.50 M(-22.5%) | -$7.03 M(-12.4%) |
| Mar 2010 | - | -$1.94 M(+22.8%) | -$8.03 M(+1.9%) |
| Dec 2009 | -$7.88 M(-41.2%) | -$1.58 M(-21.9%) | -$7.88 M(-15.3%) |
| Sep 2009 | - | -$2.02 M(-19.3%) | -$9.31 M(-12.7%) |
| Jun 2009 | - | -$2.50 M(+40.0%) | -$10.66 M(-11.2%) |
| Mar 2009 | - | -$1.79 M(-40.4%) | -$12.01 M(-10.4%) |
| Dec 2008 | -$13.40 M(+41.0%) | -$3.00 M(-11.2%) | -$13.40 M(+2.1%) |
| Sep 2008 | - | -$3.38 M(-12.3%) | -$13.12 M(-8.8%) |
| Jun 2008 | - | -$3.85 M(+21.2%) | -$14.38 M(+20.2%) |
| Mar 2008 | - | -$3.18 M(+16.8%) | -$11.96 M(+25.9%) |
| Dec 2007 | -$9.50 M(+280.3%) | -$2.72 M(-41.3%) | -$9.50 M(+29.3%) |
| Sep 2007 | - | -$4.64 M(+224.8%) | -$7.35 M(+110.2%) |
| Jun 2007 | - | -$1.43 M(+99.7%) | -$3.49 M(+69.8%) |
| Mar 2007 | - | -$714.90 K(+26.3%) | -$2.06 M(+52.4%) |
| Dec 2006 | -$2.50 M(>+9900.0%) | -$566.20 K(-27.9%) | -$1.35 M(+70.7%) |
| Sep 2006 | - | -$785.10 K(-8823.3%) | -$790.40 K(+8985.1%) |
| Jun 2006 | - | $9000.00(-225.0%) | -$8700.00(-57.8%) |
| Mar 2006 | - | -$7200.00(+1.4%) | -$20.60 K(+9.6%) |
| Dec 2005 | -$18.90 K(-0.5%) | -$7100.00(+108.8%) | -$18.80 K(-14.2%) |
| Sep 2005 | - | -$3400.00(+17.2%) | -$21.90 K(-0.5%) |
| Jun 2005 | - | -$2900.00(-46.3%) | -$22.00 K(0.0%) |
| Mar 2005 | - | -$5400.00(-47.1%) | -$22.00 K(+15.2%) |
| Dec 2004 | -$19.00 K(+17.3%) | -$10.20 K(+191.4%) | -$19.10 K(+33.6%) |
| Sep 2004 | - | -$3500.00(+20.7%) | -$14.30 K(+31.2%) |
| Jun 2004 | - | -$2900.00(+16.0%) | -$10.90 K(-27.3%) |
| Mar 2004 | - | -$2500.00(-53.7%) | -$15.00 K(-7.4%) |
| Dec 2003 | -$16.20 K(-9.0%) | -$5400.00(+5300.0%) | -$16.20 K(+11.0%) |
| Sep 2003 | - | -$100.00(-98.6%) | -$14.60 K(-36.8%) |
| Jun 2003 | - | -$7000.00(+89.2%) | -$23.10 K(-16.6%) |
| Mar 2003 | - | -$3700.00(-2.6%) | -$27.70 K(+55.6%) |
| Dec 2002 | -$17.80 K(-20.2%) | -$3800.00(-55.8%) | -$17.80 K(+6.0%) |
| Sep 2002 | - | -$8600.00(-25.9%) | -$16.80 K(+30.2%) |
| Jun 2002 | - | -$11.60 K(-287.1%) | -$12.90 K(+87.0%) |
| Mar 2002 | - | $6200.00(-321.4%) | -$6900.00(-68.9%) |
| Dec 2001 | -$22.30 K(-38.9%) | -$2800.00(-40.4%) | -$22.20 K(+14.4%) |
| Sep 2001 | - | -$4700.00(-16.1%) | -$19.40 K(+32.0%) |
| Jun 2001 | - | -$5600.00(-38.5%) | -$14.70 K(+61.5%) |
| Mar 2001 | - | -$9100.00 | -$9100.00 |
| Dec 2000 | -$36.50 K(>+9900.0%) | - | - |
| Dec 1999 | -$200.00 | - | - |
FAQ
- What is Capricor Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Capricor Therapeutics?
- What is Capricor Therapeutics annual EBIT year-on-year change?
- What is Capricor Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly EBIT year-on-year change?
- What is Capricor Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Capricor Therapeutics?
- What is Capricor Therapeutics TTM EBIT year-on-year change?
What is Capricor Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CAPR is -$24.08 M
What is the all time high annual EBIT for Capricor Therapeutics?
Capricor Therapeutics all-time high annual earnings before interest & taxes is $2.83 M
What is Capricor Therapeutics annual EBIT year-on-year change?
Over the past year, CAPR annual earnings before interest & taxes has changed by +$5.62 M (+18.92%)
What is Capricor Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CAPR is -$13.01 M
What is the all time high quarterly EBIT for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly earnings before interest & taxes is $12.39 M
What is Capricor Therapeutics quarterly EBIT year-on-year change?
Over the past year, CAPR quarterly earnings before interest & taxes has changed by -$1.42 M (-12.24%)
What is Capricor Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CAPR is -$36.15 M
What is the all time high TTM EBIT for Capricor Therapeutics?
Capricor Therapeutics all-time high TTM earnings before interest & taxes is $2.83 M
What is Capricor Therapeutics TTM EBIT year-on-year change?
Over the past year, CAPR TTM earnings before interest & taxes has changed by -$6.15 M (-20.48%)